|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,164.00 DKK | -3.86% |
|
-0.09% | +6.76% |
| 01-15 | Jyske Bank Raises Genmab Target Price to 2,300 Danish Kroner (2,000), Reiterates Hold - BN | FW |
| 01-14 | Genmab A/S Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 03:45 PM |
| Capitalization | 133B 20.71B 17.84B 16.63B 15.47B 28.77B 1,871B 30.87B 191B 75.17B 895B 77.66B 76.07B 3,282B | P/E ratio 2025 * |
18.4x | P/E ratio 2026 * | 22x |
|---|---|---|---|---|---|
| Enterprise value | 111B 17.3B 14.9B 13.89B 12.92B 24.03B 1,563B 25.78B 160B 62.78B 747B 64.86B 63.54B 2,741B | EV / Sales 2025 * |
4.69x | EV / Sales 2026 * | 3.74x |
| Free-Float |
95.94% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Genmab A/S
| 1 day | -3.86% | ||
| 1 week | -0.09% | ||
| Current month | +6.76% | ||
| 1 month | +7.39% | ||
| 3 months | +3.79% | ||
| 6 months | +57.73% | ||
| Current year | +6.76% |
| 1 week | 2,114 |  | 2,257 |
| 1 month | 1,985.5 | | 2,257 |
| Current year | 1,985.5 | | 2,257 |
| 1 year | 1,157 | | 2,257 |
| 3 years | 1,157 | | 2,947 |
| 5 years | 1,157 | | 3,327 |
| 10 years | 605.5 | | 3,327 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 31/05/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 29/02/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 15/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 31/10/2003 | |
| Director/Board Member | 59 | 31/12/2014 | |
| Director/Board Member | 75 | 31/12/2014 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.92% | 3.64% | 1,412 M€ | |
| +1.28% | 0.75% | 26 M€ | |
| +4.18% | 0.56% | 1,101 M€ | |
| +1.69% | 0.45% | 31 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.86% | -0.09% | +37.40% | -21.71% | 21.63B | |
| +0.90% | -0.88% | +6.64% | +87.92% | 49.27B | |
| +0.15% | +5.63% | +88.29% | +13.80% | 44.15B | |
| -2.56% | -9.51% | +133.23% | +718.87% | 34.86B | |
| -2.80% | +5.99% | -5.66% | -26.87% | 27.38B | |
| +0.05% | +10.80% | +127.39% | -44.88% | 21.21B | |
| +0.86% | -0.72% | +176.87% | - | 13.95B | |
| -1.22% | -5.65% | +114.99% | +150.31% | 14.58B | |
| -2.15% | -9.15% | +3.72% | +259.79% | 13.61B | |
| +0.46% | -1.62% | +27.46% | +176.57% | 12.18B | |
| Average | -1.02% | +0.40% | +71.03% | +145.98% | 25.28B | |
| Weighted average by Cap. | -0.90% | +0.85% | +66.27% | +149.55% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 23.72B 3.69B 3.17B 2.96B 2.75B 5.12B 333B 5.49B 34B 13.38B 159B 13.82B 13.54B 584B | 27.42B 4.26B 3.67B 3.42B 3.18B 5.92B 385B 6.35B 39.29B 15.46B 184B 15.97B 15.65B 675B |
| Net income | 7.48B 1.16B 1B 933M 868M 1.62B 105B 1.73B 10.72B 4.22B 50.22B 4.36B 4.27B 184B | 6.41B 996M 858M 799M 744M 1.38B 89.98B 1.48B 9.19B 3.61B 43.02B 3.73B 3.66B 158B |
| Net Debt | -21.97B -3.41B -2.94B -2.74B -2.55B -4.74B -308B -5.09B -31.48B -12.39B -147B -12.8B -12.54B -541B | -30.72B -4.77B -4.11B -3.83B -3.56B -6.63B -431B -7.11B -44.02B -17.32B -206B -17.9B -17.53B -756B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 2,164.00 kr | -3.86% | 107,638 |
| 14/01/26 | 2,251.00 kr | +4.89% | 182,092 |
| 13/01/26 | 2,146.00 kr | -0.74% | 87,364 |
| 12/01/26 | 2,162.00 kr | -0.92% | 97,982 |
| 09/01/26 | 2,182.00 kr | +1.49% | 102,707 |
Delayed Quote Nasdaq Copenhagen, January 15, 2026 at 04:20 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition